ALESSANDRI, Cesare
 Distribuzione geografica
Continente #
NA - Nord America 2.579
EU - Europa 604
AS - Asia 354
SA - Sud America 20
AF - Africa 7
OC - Oceania 1
Totale 3.565
Nazione #
US - Stati Uniti d'America 2.562
IT - Italia 162
SE - Svezia 140
SG - Singapore 132
IN - India 111
CN - Cina 98
UA - Ucraina 95
FI - Finlandia 69
DE - Germania 45
GB - Regno Unito 35
IE - Irlanda 29
AR - Argentina 19
CA - Canada 14
BE - Belgio 9
RO - Romania 8
BG - Bulgaria 7
EG - Egitto 3
IR - Iran 3
MX - Messico 3
TG - Togo 3
TR - Turchia 3
KR - Corea 2
TW - Taiwan 2
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
FR - Francia 1
MC - Monaco 1
MY - Malesia 1
PK - Pakistan 1
PL - Polonia 1
RU - Federazione Russa 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 3.565
Città #
Fairfield 438
Chandler 220
Woodbridge 216
Ann Arbor 164
Seattle 151
Houston 147
Ashburn 142
Cambridge 139
Wilmington 128
Singapore 79
San Paolo di Civitate 70
Dearborn 67
Princeton 66
Beijing 64
Plano 63
Lawrence 49
Boston 45
Jacksonville 40
San Diego 40
Rome 31
Fremont 30
Dublin 29
Bremen 22
Federal 19
Andover 17
Millbury 17
Boardman 15
New York 12
Southend 12
Norwalk 11
Hefei 10
Brussels 9
Falls Church 8
Des Moines 7
Helsinki 7
Roncadelle 7
Sofia 7
Toronto 6
Santa Clara 5
Cascina 4
Levis 4
Ottawa 4
Verona 4
Auburn Hills 3
Bucharest 3
Buffalo 3
Cairo 3
Indiana 3
Istanbul 3
Kunming 3
Lomé 3
London 3
Los Angeles 3
Modena 3
Munich 3
Nanjing 3
Phoenix 3
Poggiomarino 3
Arzignano 2
Bonndorf 2
Dallas 2
Falkenstein 2
Hebei 2
Hounslow 2
Mannheim 2
Orta di Atella 2
Portici 2
Redwood City 2
San Francisco 2
San Mateo 2
Taipei 2
Torino 2
Turin 2
Xian 2
Acerra 1
Berlin 1
Bern 1
Bühl 1
Changsha 1
Chengdu 1
Chongqing 1
Como 1
Falkenberg 1
Fuzhou 1
Genova 1
Hangzhou 1
Islamabad 1
Jiaxing 1
Kish 1
Langfang 1
Las Vegas 1
Milan 1
Monaco 1
Muizenberg 1
Mykolayiv 1
Nanchang 1
Napoli 1
New Delhi 1
Newark 1
Ozzano dell'Emilia 1
Totale 2.728
Nome #
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study 150
Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease 101
Polymorphonuclear leukocyte-derived o2-reactive species activate platelets in human whole blood. 100
Association between high values of D-dimer and Tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients 100
Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. 95
HYPERFIBRINOLYSIS INCREASES THE RISK OF GASTROINTESTINAL HEMORRHAGE IN PATIENTS WITH ADVANCED CIRRHOSIS 91
Frailty in patients affected by atrial fibrillation 90
Preparation and biodistribution of (99m)technetium labelled oxidized LDL in man 87
Association between common metabolic diseases and severity of liver steatosis 83
Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies 82
IMPROVEMENT OF BLOOD-GAS LEVELS AFTER CALCIUM-HEPARIN TREATMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 78
Inhibition of tissue-factor-mediated thrombin generation by simvastatin 76
1-YEAR SURVEY OF PATIENTS WITH ADVANCED LIVER-CIRRHOSIS - PROGNOSTIC VALUE OF CLINICAL AND LABORATORY INDEXES IDENTIFIED BY THE COX REGRESSION-MODEL 75
IN-VIVO THROMBIN GENERATION AND PLATELET HYPERACTIVITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 74
Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis 73
INHIBITION OF TISSUE PLASMINOGEN-ACTIVATOR INHIBITOR BY DEFIBROTIDE IN ATHEROSCLEROTIC PATIENTS 72
IL-6-Producing, noncatecholamines secreting pheochromocytoma presenting as fever of unknown origin 70
Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis 69
Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia 68
Hydrogen peroxide as trigger of platelet aggregation. 67
Lipoprotein (a) serum levels in patients with hepatocarcinoma 67
APOLIPOPROTEINS C-II AND C-III IN PERIPHERAL ARTERIAL-DISEASE 66
Soluble P-selectin and proinflammatory cytokines in patients with polygenic type IIa hypercholesterolemia 64
PREKALLIKREIN AND FACTOR-VII AS PROGNOSTIC INDEXES OF LIVER-FAILURE 63
Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia 62
Relationship between prothrombin activation fragment F1+2 and serum cholesterol 60
LIPOPROTEIN (A) DOES NOT INFLUENCE HYPERFIBRINOLYSIS IN PATIENTS WITH LIVER-CIRRHOSIS 59
Proinflammatory cytokines and hemostatic system in patients with chronic obstructive pulmonary disease 56
Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease 56
Serum metalloproteinase 9 levels in patients with coronary artery disease: A novel marker of inflammation 55
Plasma thiobarbituric acid reactive substances a predictive marker of cerebral ischemia in patients at high risk? 55
INTERRELATION BETWEEN FACTOR-VII, PREKALLIKREIN, AND HYPERFIBRINOLYSIS IN ADVANCED CIRRHOSIS 54
PREVALENCE OF HYPERFIBRINOLYSIS IN PATIENTS WITH LIVER-CIRRHOSIS 54
High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease. 53
Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease 50
EVALUATION OF D-DIMER IN PATIENTS WITH LIVER-CIRRHOSIS 49
Chronic obstructive pulmonary disease. A possible correlation between platelet aggregation tests and respiratory indexes. ECOB Group. 48
null 47
[Effects of simvastatin on plasma lipoproteins]. 46
Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration. 44
Association between histological diagnosis of helicobacter pylory and coronary disease: results of a retrospective study 44
null 44
Alpha-linolenic acid-rich wheat germ oil decreases oxidative stress and CD40 ligand in patients with wild hypercholesterolemia 43
ARE LOW-LEVEL OF HDL2-CHOLESTEROL A RISK FACTOR FOR ATHEROSCLEROSIS OF CEREBRAL VASCULAR-DISEASE - CASE-REPORT 43
Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease 42
Frailty and disability in the elderly: A diagnostic dilemma 42
EMORRAGIA DA METASTASI CEREBRALE IN UN PAZIENTE CON EPATOCARCINOMA 40
INTRAVASCULAR CLOTTING ACTIVATION AND SYSTEMIC HYPERFIBRINOLYSIS IN PATIENTS WITH SEVERE LIVER-CIRRHOSIS - THE ROLE OF ASCITES 40
A CASE OF IATROGENIC OSTEOMYELITIS AFTER EXPLORATORY PUNCTURE OF JOINT 38
Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thrombin generation 37
Intracranial hemorrage due to brain metastases in an Italian HCV patient with hepatocellular carcinoma 37
Replay to: Lipoprotein (a) and chronic obstructive pulmonary disease. 36
Caratterizzazione clinica dei pazienti con sindrome metabolica da insulino resistenza 36
RELATIONSHIP BETWEEN LIPOPROTEIN(A) LEVELS IN SERUM AND SOME INDEXES OF PROTEIN-SYNTHESIS IN LIVER-CIRRHOSIS 33
[Relationship between blood fibrinogen and plasma lipoproteins in patients with hypercholesterolemia]. 33
DIAGNOSIS ON A CASE OF CONN DISEASE 33
Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group. 31
[The behavior of the fibrinogen polymerization curve in hypercholesterolemic subjects]. 30
Relationship between platelet cyclooxygenase pathway and plasma malondialdehyde material 27
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis (Protocol) 24
null 22
null 21
Acute renal failure associated with cocaine and alcohol abuse 20
Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases 16
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis 16
null 14
Cocaine use and acute coronary syndromes 10
Non alcoholic fatty liver disease: an hepatic consequence of common metabolic diseases 8
Tolosa-Hunt syndrome - Report of a case in clinical practice 3
null 1
Totale 3.673
Categoria #
all - tutte 10.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020722 0 0 0 39 89 132 136 100 92 72 40 22
2020/2021287 32 26 13 25 11 41 7 32 19 53 22 6
2021/2022666 5 40 70 27 76 28 19 61 47 65 101 127
2022/2023769 134 186 45 103 72 67 13 42 84 5 10 8
2023/2024227 16 48 4 19 21 17 10 8 2 37 17 28
2024/2025117 27 60 30 0 0 0 0 0 0 0 0 0
Totale 3.673